
Therapeutic breakthroughs: Our pipeline
Calluna Pharma, a powerful force in developing novel therapeutics for inflammatory and fibrotic diseases, was formed by the merger of two innovative biotech companies, Arxx Therapeutics and Oxitope Pharma BV. By combining expertise in targeting the root causes of these conditions, Calluna aims to revolutionize treatment options and significantly improve patient outcomes.
Our pipeline
CAL101 Idiopathic pulmonary fibrosis (IPF)
S100A4
CAL103 Chronic pipeline
OxPL
*In partnership with Lilly ExploR&D™